Seeking Alpha
28 Oct 2026, 14:50 UTC · 48m ago
Medtronic: Broader Growth, Attractive Valuation
Impact · against what's priced in
The report is largely a confirmation of existing expectations, as the 7% organic growth is already baked into the current valuation. The only meaningful catalyst is the December Investor Day, which may provide the clarity needed to resolve the earnings uncertainty the market is currently ignoring.
- MDT+0.00
Already priced in
- The price assumes
Fiscal 2027 organic revenue growth of 7.25%–7.75%
The reported ~7% organic revenue growth for Q1 FY2027 aligns almost exactly with the growth rates the market has already priced in.
What MDT's price assumes · Sep 9
